EUVIMEDEUVIMED entdecken
Open Access

Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation

Christopher Strouse iD, Mark Juckett, Brent R Logan iD, Noel Estrada-Merly iD, Andrew Peterson, Jaime M Preussler iD, Tony H Truong iD, Jesse D Troy, Nandita Khera iD, William A Wood iD, Hemalatha G Rangarajan, Luke P Akard und 4 weitere

JCO Oncology Practice · 2025

DOI: 10.1200/op-25-00115 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JCO Oncology Practice, 2025. Verfasst von Christopher Strouse und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA. Hauptthemen laut MEDLINE: Hematopoietic Stem Cell Transplantation, Patient Selection, Outcome Assessment, Health Care. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIEHS NIH HHS, NIAID NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE Public reporting of health care outcomes can have unintended effects such as inappropriate risk aversion in patient selection. METHODS The center-specific survival analysis annually assigns all hematopoietic cell transplantation (HCT) centers in the United States a +1, −1, or 0 score for observed outcomes that are above, below, or within a center-specific predicted range of outcome. For each index year (2012-2016), centers receiving a −1 score after 0 scores in the preceding 2 years were compared with contemporaneous centers with as-predicted outcomes (0 score). Changes in the patient population characteristics in the 3 years before versus the 3 years after the index years were compared between the newly below-expected centers (NBCs) and the controls. A multivariate model adjusted for baseline patient population characteristics and center volume. RESULTS No differences in patient selection behavior were identified when comparing the NBCs with the controls across eight key patient population characteristics. For the statistically modeled (predicted) 1-year overall survival (OS), reflecting a holistic measure of centers' patient population risk, we observed no statistically significant difference in change (−0.23% [95% CI, −1.4 to 0.9]; P = .70). The observed OS increased in both NBCs and controls by 0.9% and 4.5%, respectively, without statistically significant difference in change. CONCLUSION Centers receiving a −1 score were not observed to deviate significantly from patient selection trends in the HCT field. These findings suggest that public reporting of HCT outcomes in the United States does not result in unintended bias against HCT for high-risk patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematopoietic Stem Cell TransplantationPatient SelectionOutcome Assessment, Health CareHumansMaleFemaleMiddle AgedAdultUnited States

Autor:innen und Institutionen

  • Division of Hematology, Oncology and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA.
  • Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.
  • Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI.
  • Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI.
  • National Marrow Donor Program/Be The Match, Minneapolis, MN.
  • Division of Pediatric Oncology, Blood and Marrow Transplant, Alberta Children's Hospital, Calgary, AB, Canada.

ORCID-Profile: Christopher Strouse, Brent R Logan, Noel Estrada-Merly, Jaime M Preussler, Tony H Truong, Nandita Khera, William A Wood, Neel S Bhatt, Akshay Sharma, J Douglas Rizzo, Wael Saber

Förderung

  • NIEHS NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Strouse, C., Juckett, M., Logan, B. R., Estrada-Merly, N., Peterson, A., Preussler, J. M., Truong, T. H., Troy, J. D., Khera, N., Wood, W. A., Rangarajan, H. G., Akard, L. P., Bhatt, N. S., Sharma, A., Rizzo, J. D., & Saber, W. (2025). Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. JCO Oncology Practice. https://doi.org/10.1200/op-25-00115

Vancouver

Strouse C, Juckett M, Logan BR, Estrada-Merly N, Peterson A, Preussler JM, et al. Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation. JCO Oncology Practice. 2025. doi:10.1200/op-25-00115

BibTeX
@article{Strouse2025,
  author = {Strouse, Christopher and Juckett, Mark and Logan, Brent R and Estrada-Merly, Noel and Peterson, Andrew and Preussler, Jaime M and Truong, Tony H and Troy, Jesse D and Khera, Nandita and Wood, William A and Rangarajan, Hemalatha G and Akard, Luke P and Bhatt, Neel S and Sharma, Akshay and Rizzo, J Douglas and Saber, Wael},
  title = {Impact of Publicly Reported Outcomes on Patient Selection for Hematopoietic Cell Transplantation},
  journal = {JCO Oncology Practice},
  year = {2025},
  doi = {10.1200/op-25-00115}
}
Kostenlos starten →